Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol in patients undergoing cardiac surgery
ChiCTR2300072428Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esmolol in cardiac disease (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: heart rate. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
esmolol
03
Conditions
cardiac disease
Beyond the preview
Go deeper on ChiCTR2300072428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072428.